These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9075489)

  • 1. Aggressive lipid-lowering therapy beneficial after bypass grafting, say researchers.
    Am J Health Syst Pharm; 1997 Mar; 54(6):626. PubMed ID: 9075489
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.
    Post Coronary Artery Bypass Graft Trial Investigators
    N Engl J Med; 1997 Jan; 336(3):153-62. PubMed ID: 8992351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial.
    White CW; Gobel FL; Campeau L; Knatterud GL; Forman SA; Forrester JS; Geller NL; Herd JA; Hickey A; Hoogwerf BJ; Hunninghake DB; Rosenberg Y; Terrin ML;
    Circulation; 2001 Nov; 104(22):2660-5. PubMed ID: 11723015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keeping vessels clear after bypass surgery.
    Harv Heart Lett; 2000 Dec; 11(4):5-6. PubMed ID: 11114793
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipid-lowering therapy after coronary artery bypass surgery: the Post-CABG trial.
    Stewart WJ; Hoogwerf BJ
    Cleve Clin J Med; 1997; 64(7):347-51. PubMed ID: 9223762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-lowering therapy after coronary artery bypass grafting: time for more aggressive intervention.
    Lucas BD
    Am J Health Syst Pharm; 2002 Nov; 59(21):2101-3. PubMed ID: 12434726
    [No Abstract]   [Full Text] [Related]  

  • 7. Pleiotropic effect of lovastatin, with and without cholestyramine, in the post coronary artery bypass graft (Post CABG) trial.
    Domanski M; Tian X; Fleg J; Coady S; Gosen C; Kirby R; Sachdev V; Knatterud G; Braunwald E
    Am J Cardiol; 2008 Oct; 102(8):1023-7. PubMed ID: 18929703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of atherosclerosis in coronary-artery bypass grafts.
    Fuster V; Vorchheimer DA
    N Engl J Med; 1997 Jan; 336(3):212-3. PubMed ID: 8988902
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of nicotinic acid and lovastatin in combination with cholestyramine in renal transplant patients.
    Lal SM; Katyal A
    Mo Med; 2002; 99(10):580-4. PubMed ID: 12534147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol consumption, atherosclerotic progression, and prognosis among patients with coronary artery bypass grafts.
    Mukamal KJ; Girotra S; Mittleman MA
    Am Heart J; 2006 Feb; 151(2):368-72. PubMed ID: 16442902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate alcohol consumption and safety of lovastatin and warfarin among men: the post-coronary artery bypass graft trial.
    Mukamal KJ; Smith CC; Karlamangla AS; Moore AA
    Am J Med; 2006 May; 119(5):434-40. PubMed ID: 16651056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the addition of fenofibrate to the simvastatin-cholestyramine combination].
    Schlienger JL
    Presse Med; 1991 Mar; 20(12):565. PubMed ID: 1827899
    [No Abstract]   [Full Text] [Related]  

  • 13. Four years' treatment efficacy of patients with severe hyperlipidemia. Lipid lowering drugs versus LDL-apheresis.
    Schiel R; Bambauer R; Müller UA
    Int J Artif Organs; 1995 Dec; 18(12):786-93. PubMed ID: 8964646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. I'm 79 years-old and had a triple bypass about 10 years ago. I took to heart your advice to lower my LDL cholesterol. With my doctor's support, I started daily doses of lovastatin (Mevacor) and cholestyramine (Prevalite). After five weeks, my LDL cholesterol was 87, and my total cholesterol was 164. So, how long should I pursue such aggressive therapy?
    Harv Heart Lett; 1998 Apr; 8(8):8. PubMed ID: 9549441
    [No Abstract]   [Full Text] [Related]  

  • 15. Preoperative lipid control with simvastatin protects coronary artery bypass grafts from obstructive graft disease.
    Christenson JT
    Am J Cardiol; 2001 Oct; 88(8):896-9, A8. PubMed ID: 11676957
    [No Abstract]   [Full Text] [Related]  

  • 16. Choice of cholesterol-lowering drugs.
    Med Lett Drugs Ther; 1991 Jan; 33(835):1-4. PubMed ID: 1984601
    [No Abstract]   [Full Text] [Related]  

  • 17. Fenofibrate, probucol, and other lipid-lowering treatments in heart transplant recipients.
    de Lorgeril M; Boissonnat P; Salen P; Monjaud I; Dureau G
    J Heart Lung Transplant; 1996 May; 15(5):539-40. PubMed ID: 8771511
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tinnitus and lipid metabolism disorders. Value of early normolipemic treatment].
    Albertini F
    Sem Hop Ther; 1977 Apr; 53(4):261-3. PubMed ID: 882873
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
    Denke MA; Grundy SM
    Arch Intern Med; 1995 Feb; 155(4):393-9. PubMed ID: 7848022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost-effectiveness of lowering of blood cholesterol using simvastatin and cholestyramine].
    Martens LL; Rutten FF; Kuijpens JL; Winter J
    Ned Tijdschr Geneeskd; 1991 Apr; 135(15):655-9. PubMed ID: 1903849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.